English | Español
Press release submission | May 21, 2022

Good Days Partners With Annexus Health to Streamline the Patient Assistance Enrollment Process for Patients With Retinal Disease

Press release submission | May 20, 2022

Karyopharm and Menarini Group Receive Positive CHMP Opinion for NEXPOVIO® (selinexor) for the Treatment of Patients with Refractory Multiple Myeloma

Press release submission | May 20, 2022

CarolinaEast Medical Center Among Nation's Top Performing Hospitals for Treatment of Heart Attack Patients

Press release submission | May 18, 2022

New FAIR Health Study Reports 76 Percent of Patients Diagnosed with Post-COVID Conditions Had Never Been Hospitalized for COVID-19

Press release submission | May 14, 2022

New Real-World Evidence Shows Improvements in Outcomes and Reduction in Healthcare Costs with Guidance® UTI Precision Diagnostic Test Compared to Standard Urine Culture in Patients with Complicated Urinary Tract Infections

Press release submission | May 13, 2022

Glycostem announces new data presentation at EHA 2022 Congress highlighting early safety and clinical course of oNKord® in patients with Acute Myeloid Leukemia

Press release submission | May 13, 2022

Studies Debunk COVID-19 Fertility & Transplant Concerns; Long-term Impact of COVID Yet to be Realized in Prostate & Bladder Cancer Patients

Press release submission | May 13, 2022

Baili Announces Clinical Trial Collaboration to Evaluate SI-B001, an EGFR x HER3 bispecific Antibody, in Combination with Tagrisso® in Patients with Non-Small Cell Lung Cancer

Trending
Patient Daily | Jul 15, 2025

Scottsdale Sinus & Allergy Center garners 500+ Google reviews with a 4.9-star rating
Patient Daily | Jul 11, 2025

Physician assistant on headaches and sinusitis: ‘Sinus headaches are known to trigger your migraines’
Patient Daily | Jul 15, 2025

Gulf Coast Breathe Free Sinus & Allergy Centers earns 250+ Google reviews with a 4.9-star rating
+ Pharmaceuticals
Patient Daily | Jul 10, 2025

PhRMA Executive VP: ‘State policymakers can lead the way and must address 340B abuse and protect patients from PBMs'